FOLFIRINOX-R
Institut du Cancer de Montpellier - Val d'Aurelle
Institut du Cancer de Montpellier - Val d'Aurelle
Bristol-Myers Squibb
NantCell, Inc.
Alaunos Therapeutics
Vedanta Biosciences, Inc.
Eisai Inc.
Incyte Corporation
Bristol-Myers Squibb
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Incyte Corporation
Bristol-Myers Squibb
Nektar Therapeutics
Hoffmann-La Roche
NGM Biopharmaceuticals, Inc
Numab Therapeutics AG
Hutchmed
Thomas Jefferson University
Menarini Group
NuCana plc
HiberCell, Inc.
Cardiff Oncology
Sarcoma Oncology Research Center, LLC
Case Comprehensive Cancer Center
ImmunityBio, Inc.
M.D. Anderson Cancer Center
Sellas Life Sciences Group
AstraZeneca
Vanderbilt-Ingram Cancer Center
NantCell, Inc.
NantBioScience, Inc.
Academic and Community Cancer Research United
Massachusetts General Hospital
Kyowa Kirin Co., Ltd.
Georgetown University
Cellestia Biotech AG
Eisai Inc.
Hoffmann-La Roche
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
Genmab
Genmab
Revolution Medicines, Inc.
Nektar Therapeutics
Nektar Therapeutics
Brown University
Ludwig Institute for Cancer Research
Roswell Park Cancer Institute
Incyte Corporation
Silverback Therapeutics